Several firms are bringing high-sensitivity cardiac troponin testing into the ER, although doctors are not yet certain how ...

The firm will use the money to help advance the development of its digital slide image sharing platform, invest in personnel, and reach regulatory milestones.

The company said the parties had not met certain milestones required for commercialization of the test, which predicts risk of diabetic kidney disease.

Stratipath Breast risk stratifies breast cancer by analyzing digitized histopathology slides of breast cancer tissue.

Rome-based Policlinico Gemelli will establish an in-house liquid biopsy testing service within its hospital system utilizing Guardant360 CDx.

GenomOncology's Pathology Workbench will be used as the clinical genomic reporting platform for Precipio's myeloid neoplasm test.

The firm said that it plans to use the money to help launch its diagnostics division, expand its testing menu, and hire a chief operating officer.

Labcorp will operate the system's outreach services while Ballad will continue to operate services including its inpatient and emergency department laboratories.

NEW YORK – The US Food and Drug Administration in August granted 510(k) marketing clearance for immunoassays for various infectious diseases Toxoplasma gondii infection, syphilis, mononucleosis, Lyme ...

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...